Development of downstream processing to minimize beta-glucan impurities in GMP-manufactured therapeutic antibodies. (2016)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/btpr.2359
PubMed Identifier: 27604040
Publication URI: http://europepmc.org/abstract/MED/27604040
Type: Journal Article/Review
Volume: 32
Parent Publication: Biotechnology progress
Issue: 6
ISSN: 1520-6033